![](/img/cover-not-exists.png)
Phase I Study Assessing the Safety and Tolerability of Barasertib (AZD1152) With Low-Dose Cytosine Arabinoside in Elderly Patients With AML
Kantarjian, Hagop M., Sekeres, Mikkael A., Ribrag, Vincent, Rousselot, Philippe, Garcia-Manero, Guillermo, Jabbour, Elias J., Owen, Kate, Stockman, Paul K., Oliver, Stuart D.Volume:
13
Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2013.03.019
Date:
October, 2013
File:
PDF, 739 KB
english, 2013